Ono Pharmaceutical Co. Ltd. | Ownership
Companies that own Ono Pharmaceutical Co. Ltd.
Wellington Management Co. LLP
37,046,267
6.82%
4,012,607
0.18%
10/31/2017
The Vanguard Group, Inc.
10,760,531
1.98%
45,300
0.01%
07/31/2018
Nomura Asset Management Co., Ltd.
9,221,697
1.7%
-2,380,957
0.14%
07/31/2018
BlackRock Fund Advisors
6,934,500
1.28%
-2,900
0.01%
09/06/2018
Norges Bank Investment Management
5,264,190
0.97%
410,479
0.02%
12/31/2017
Daiwa Asset Management Co. Ltd.
4,469,898
0.82%
207,898
0.13%
07/31/2018
Nikko Asset Management Co., Ltd.
3,976,999
0.73%
-102,201
0.06%
09/03/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
2,836,900
0.52%
870,400
0.16%
04/09/2018
BlackRock Advisors (UK) Ltd.
1,761,595
0.32%
12,200
0.02%
09/06/2018
AllianceBernstein LP
1,620,764
0.3%
-3,282
0.02%
07/31/2018
| Address |
1-8-2 Kyutaromachi
Osaka Osaka 541
Japan
|
|
Employees
|
- |
| Website |
http://www.ono.co.jp |
| Updated |
07/08/2019 |
| Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan. . |
